CRISPR/Cas9 for hepatitis B virus infection treatment

Hepatitis B virus (HBV) infection remains a global health challenge. Despite the availability of effective preventive vaccines, millions of people are at risk of cirrhosis and hepatocellular carcinoma. Current drug therapies inhibit viral replication, slow the progression of liver fibrosis and reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Bo, Chang, Shixue, Tian, Yuhan, Zhen, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170306/
https://www.ncbi.nlm.nih.gov/pubmed/37249290
http://dx.doi.org/10.1002/iid3.866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170306/
https://www.ncbi.nlm.nih.gov/pubmed/37249290
http://dx.doi.org/10.1002/iid3.866

Ejemplares similares